<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (MS) is a <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">genetic disorder</z:e> caused by a mutation in the fibrillin gene FBN1 </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0001647'>Bicuspid aortic valve</z:hpo> (<z:mp ids='MP_0010484'>BAV</z:mp>) is a congenital heart malformation of unknown cause </plain></SENT>
<SENT sid="2" pm="."><plain>Both conditions are associated with <z:hpo ids='HP_0002631'>ascending aortic aneurysm</z:hpo> and premature <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>This study examined the relationship among the secretion of extracellular matrix proteins fibrillin, fibronectin, tenascin, and vascular smooth muscle cell (VSMC) <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>The role of matrix metalloproteinase (MMP)-2 in VSMC <z:mpath ids='MPATH_3'>apoptosis</z:mpath> was studied in MS <z:hpo ids='HP_0002617'>aneurysm</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>METHODS AND RESULTS: <z:hpo ids='HP_0002617'>Aneurysm</z:hpo> tissue was obtained from patients undergoing surgery (MS: 4 M, 1 F, age 27-45 years; <z:mp ids='MP_0010484'>BAV</z:mp>: 3 M, 2 F, age 28-65 years) </plain></SENT>
<SENT sid="6" pm="."><plain><z:mpath ids='MPATH_458'>Normal</z:mpath> aorta from subjects with nonaneurysm disease was also collected (4 M, 1 F, age 23-93 years) </plain></SENT>
<SENT sid="7" pm="."><plain>MS and <z:mp ids='MP_0010484'>BAV</z:mp> <z:hpo ids='HP_0002617'>aneurysm</z:hpo> histology showed areas of cystic medial <z:mp ids='MP_0001651'>necrosis</z:mp> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMN</z:e>) without inflammatory infiltrate </plain></SENT>
<SENT sid="8" pm="."><plain>Immunohistochemical study of cultured MS and <z:mp ids='MP_0010484'>BAV</z:mp> VSMC showed intracellular accumulation and reduction of extracellular distribution of fibrillin, fibronectin, and tenascin </plain></SENT>
<SENT sid="9" pm="."><plain>Western blot showed no increase in expression of fibrillin, fibronectin, or tenascin in MS or <z:mp ids='MP_0010484'>BAV</z:mp> VSMC and increased expression of MMP-2 in MS VSMCs </plain></SENT>
<SENT sid="10" pm="."><plain>There was 4-fold increase in loss of cultured VSMC incubated in serum-free medium for 24 hours in both MS (27+/-8%) and <z:mp ids='MP_0010484'>BAV</z:mp> (32+/-14%) compared with control (7+/-5%) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: In MS and <z:mp ids='MP_0010484'>BAV</z:mp> there is alteration in both the amount and quality of secreted proteins and an increased degree of VSMC <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="12" pm="."><plain>Up-regulation of MMP-2 might play a role in VSMC <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in MS VSMC </plain></SENT>
<SENT sid="13" pm="."><plain>The findings suggest the presence of a fundamental cellular abnormality in <z:mp ids='MP_0010484'>BAV</z:mp> thoracic aorta, possibly of genetic origin </plain></SENT>
</text></document>